# Artifact Evaluations by R-Testing

> Schema: `.github/agents/evaluation-schema.md`

```yaml
artifact_evaluation:
  evaluator: "r-testing"
  source_artifact: "design.md"
  usefulness_score: 9
  clarity_score: 9
  useful_elements:
    - "§12 Testing Strategy — provided exact test IDs (T-1 through T-13, T-N1 through T-N4) with AC mappings, enabling systematic coverage gap analysis"
    - "§3.1–§3.9 exact before/after text for each edit point — made it possible to verify v-tests search strings match design intent"
    - "§14 CT Findings Disposition — clarified which findings were addressed vs. deferred, useful for understanding what should NOT have been tested"
  missing_information:
    - "T-N1 and T-N2 descriptions are ambiguous — the names ('Memory Lifecycle table still exists', 'Merge steps still exist') don't specify what text to search for, leading to v-tests remapping them to different checks"
  information_not_used:
    - "§5–§6 Data Models and APIs sections (all 'No Changes') — not relevant to test review"
    - "§15 Phase 2 Future Work — entirely out of scope for Phase 1 test review"
  inaccuracies:
    - "N/A — none identified"
  impact_on_work:
    - "N/A — none identified"
```

```yaml
artifact_evaluation:
  evaluator: "r-testing"
  source_artifact: "feature.md"
  usefulness_score: 7
  clarity_score: 7
  useful_elements:
    - "§Acceptance Criteria (AC-1 through AC-15) — provided the ground truth for what behaviors tests should verify"
    - "§Phase 1 Scope — clearly delineated which 5 ACs are in-scope, preventing false coverage gap reports for deferred ACs"
    - "§Test Scenarios (TS-1 through TS-11) — useful cross-reference for understanding intended test coverage at the feature level"
  missing_information:
    - "AC-3 pass criterion ('returns zero matches') is ambiguous — it conflicts with the necessity to name prohibited tools in prohibition contexts. The Phase 1 interpretation (pragmatic: zero matches in allowed-tool contexts) is correct but had to be inferred"
  information_not_used:
    - "§FR-2 through §FR-5 — all relate to Phase 2 (memory.md elimination, subagent updates) and were not relevant to Phase 1 test review"
    - "§Edge Cases EC-3 through EC-8 — all relate to Phase 2 behaviors"
  inaccuracies:
    - "AC-12 pass criterion says Anti-Drift Anchor 'does not mention memory.md' but Phase 1 preserves memory.md — the Phase 1 Scope annotation correctly addresses this but the original AC text is technically inaccurate for Phase 1"
  impact_on_work:
    - "AC-3 ambiguity required cross-referencing design §3.3 and v-feature's pragmatic interpretation to confirm the tests used the correct criterion"
```
